GRLIF (SR Medical Technology Co) Financial Strength: 3 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRLIF SR Medical Technology Co Ltd GRLIF
43 GF Score
Price $0.21
! 6 Warning Signs
View Full Analysis

What is SR Medical Technology Co Financial Strength?

SR Medical Technology Co GRLIF 43 Financial Strength is 3 as of Dec. 2025. GuruFocus rates GRLIF with a GF Score™ of 43/100. The stock has 6 warning signs investors should review.

SR Medical Technology Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.

Warning Sign:

SR Medical Technology Co Ltd displays poor financial strength. Usually, this is caused by too much debt for the company.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

SR Medical Technology Co's Interest Coverage for the quarter that ended in Dec. 2025 was 0.03. SR Medical Technology Co's debt to revenue ratio for the quarter that ended in Dec. 2025 was 9.19. As of today, SR Medical Technology Co's Altman Z-Score is 0.80.


SR Medical Technology Co  (OTCPK:GRLIF) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

SR Medical Technology Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.


SR Medical Technology Co Financial Strength Related Terms


GRLIF vs CBRE, BEKE, JLL: Financial Strength Comparison

For the Real Estate Services subindustry, SR Medical Technology Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SR Medical Technology Co Financial Strength vs Real Estate Industry

For the Real Estate industry and Real Estate sector, SR Medical Technology Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where SR Medical Technology Co's Financial Strength falls into.


GRLIF
43GF Score
SR Medical Technology Co Ltd GRLIF
Financial Strength is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SR Medical Technology Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

SR Medical Technology Co's Interest Expense for the months ended in Dec. 2025 was $-11.89 Mil. Its Operating Income for the months ended in Dec. 2025 was $0.33 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $210.36 Mil.

SR Medical Technology Co's Interest Coverage for the quarter that ended in Dec. 2025 is

Interest Coverage=-1*Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*0.331/-11.886
=0.03

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. SR Medical Technology Co Ltds earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.

2. Debt to revenue ratio. The lower, the better.

SR Medical Technology Co's Debt to Revenue Ratio for the quarter that ended in Dec. 2025 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2025 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(161.07 + 210.359) / 40.404
=9.19

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

SR Medical Technology Co has a Z-score of 0.80, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of 0.8 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Financial Strength →
What does a Financial Strength of 3 mean?
SR Medical Technology Co (GRLIF) has a Financial Strength of 3 as of Dec. 2025. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on SR Medical Technology Co and its competitors.
Is SR Medical Technology Co's Financial Strength too high?
SR Medical Technology Co's current Financial Strength is 3. Overall, SR Medical Technology Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does SR Medical Technology Co's Financial Strength compare to CBRE and BEKE?
SR Medical Technology Co's Financial Strength of 3 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for a Real Estate company?
A good Financial Strength depends on the Real Estate industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on SR Medical Technology Co and its competitors. SR Medical Technology Co's current Financial Strength is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SR Medical Technology Co stock overvalued right now?
SR Medical Technology Co (GRLIF) has a current Financial Strength of 3. The current Financial Strength is 3. SR Medical Technology Co's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For SR Medical Technology Co (GRLIF), the current Financial Strength is 3 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SR Medical Technology Co Business Description

Other Exchanges 00108:Hong Kong
Address 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Ruttonjee Centre, Hong Kong, HKG
GR Life Style Co Ltd is an investment holding company. The Group is principally engaged in the property development and investments in the PRC, the USA and the UK, and the provision of property management services in the PRC. The Group has two reportable operating segments: the property development and investment segment, which engages in property development and investment in the UK, the USA and Chinese Mainland; and the property management segment, which engages in the provision of property management and other services for office buildings, residential properties and car parks in Chinese Mainland. The Group operates in Chinese Mainland with maximum revenue, the UK, and the USA.
43GF Score

Get the complete analysis for GRLIF

Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price